Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 35: 1722-1725, 1989;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohshima, T.
Right arrow Articles by Kitazawa, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohshima, T.
Right arrow Articles by Kitazawa, S.

Clinical Chemistry, Vol 35, 1722-1725, Copyright © 1989 by American Association for Clinical Chemistry

Variations in protein binding of drugs in plasma and serum

T Ohshima, T Hasegawa, I Johno and S Kitazawa
Department of Hospital Pharmacy, School of Medicine, Nagoya University, Japan.

The free fractions of five drugs were determined in plasma treated with EDTA and in serum. The free fractions of phenytoin, sodium valproate, and phenobarbital in serum were significantly higher than in plasma (P less than 0.05). In contrast, the free fractions of carbamazepine and theophylline were significantly lower in serum than in plasma. Although we observed minor differences in the protein patterns obtained with two- dimensional electrophoresis, these did not have an important influence on protein binding. No significant differences were observed between plasma and serum in the physiological data, except for pH. Binding of these drugs by protein was shown to be pH-dependent. We conclude that serum may be better than plasma for determination of the free fraction, because the free fraction in plasma is affected by anticoagulants such as EDTA salts and heparin.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
M. Burt, D. C. Anderson, J. Kloss, and F. S. Apple
Evidence-based Implementation of Free Phenytoin Therapeutic Drug Monitoring
Clin. Chem., August 1, 2000; 46(8): 1132 - 1135.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Warner, M. Privitera, and D. Bates
Standards of laboratory practice: antiepileptic drug monitoring
Clin. Chem., May 1, 1998; 44(5): 1085 - 1095.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American Association for Clinical Chemistry.